Clinical Trial Update: Adjuvant Post-Tamoxifen Exemestane Trial [Phase 3]

View source ↗

Summary

Phase 3 adjuvant exemestane trial following tamoxifen for breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

Sponsor: Hellenic Breast Surgeons Society | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED